STOCKSFor These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1By Adam FeuersteinApr 11, 2017 1:46 PM EDT
INVESTINGValue investors have to go deeper in these exuberant marketsBy Jim CollinsFeb 23, 2017 4:59 PM EST
STOCKSGilead Sciences Leads Biotech Movers -- Plus Jim Cramer's CommentsBy Alicia McElhaneyFeb 8, 2017 10:00 AM EST
STOCKSHow to expertly trade Monday's most active stocks -- AMD, Galena Pharma, Hasbro and moreBy Jonas ElmerrajiFeb 6, 2017 1:20 PM EST
MARKETSPost-Trump rally stalls as Dow Jones slips further from 20,000 markBy Valerie YoungDec 28, 2016 4:21 PM EST
MARKETSStocks Slump as all S&P 500 Sectors in Negative TerritoryBy Valerie YoungDec 28, 2016 2:39 PM EST
VIDEOStocks Snatch Earlier Gains as Dow Moves Away from 20,000 MarkBy Valerie YoungDec 28, 2016 11:53 AM EST
MARKETSStocks turn negative, prolonging Dow's Trek Toward 20,000By Valerie YoungDec 28, 2016 10:53 AM EST
STOCKSWhat Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016By Adam FeuersteinDec 22, 2016 11:20 AM EST
OPINION2 big-volume stocks to add to your buy list -- plus 5 risky ones to avoidBy Jonas ElmerrajiJun 29, 2016 2:50 PM EDT
STOCKSGalena craters on breast cancer vaccine study failureBy Adam FeuersteinJun 29, 2016 8:24 AM EDT
MARKETSGalena (GALE) Stock Soared Today, Breast Cancer Treatment Received 'Fast Track' DesignationBy Rachel GrafJun 1, 2016 4:06 PM EDT
MARKETSHere’s Why Galena Biopharma (GALE) Stock is Spiking TodayBy Kaya YurieffMar 29, 2016 12:42 PM EDT
STOCKSGalena Not Named Target of Federal Criminal Probe Into Painkiller UseBy Adam FeuersteinMar 11, 2016 2:17 PM EST
STOCKS2016 Biotech Stock Prediction: It's going to be a bummer year, folksBy Adam FeuersteinJan 9, 2016 3:00 PM EST
MARKETSGalena Biopharma (GALE) Stock Rating Upgraded at OppenheimerBy Amanda AlbrightNov 12, 2015 9:06 AM EST
MARKETSGalena Biopharma (GALE) Stock Declines on Earnings MissBy Amanda AlbrightNov 10, 2015 12:27 PM EST
MARKETSGalena Biopharma (GALE) Is Today's Dead Cat Bounce StockBy TheStreet WireJun 10, 2015 12:04 PM EDT
OPINION3 Big Stocks on Traders' Radars -- and What to Do With ThemBy Jonas ElmerrajiJun 8, 2015 1:38 PM EDT
MARKETSGalena Biopharma (GALE) Highlighted As Weak On High VolumeBy TheStreet WireJun 8, 2015 10:13 AM EDT
MARKETSGalena Biopharma (GALE) Stock Spikes on Promising Cancer Vaccine Study ResultsBy Tony OwusuMay 27, 2015 3:55 PM EDT
